Growth Metrics

LifeStance Health (LFST) Return on Equity (2021 - 2025)

LifeStance Health (LFST) has disclosed Return on Equity for 5 consecutive years, with 0.01% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 5.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 5.0% increase, with the full-year FY2025 number at 0.01%, up 5.0% from a year prior.
  • Return on Equity was 0.01% for Q4 2025 at LifeStance Health, up from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.01% in Q4 2025 to a low of 0.23% in Q2 2022.
  • A 5-year average of 0.11% and a median of 0.12% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: decreased -16bps in 2022, then rose 12bps in 2023.
  • LifeStance Health's Return on Equity stood at 0.19% in 2021, then grew by 26bps to 0.14% in 2022, then grew by 9bps to 0.13% in 2023, then skyrocketed by 69bps to 0.04% in 2024, then soared by 119bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for LFST's Return on Equity are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).